A fixed 'single vial' dose of subcutaneous desmopressin (DDAVP) produces adequate biologic responses for persons with mild haemophilia A

Autor:	Alex Connolly, Joseph Noye, J. Rowell, Jane A. Mason, Beryl Zeissink
Rok vydání:	2021
Předmět:	Biological Products Factor VIII business.industry Haemophilia A Hematology General Medicine medicine.disease Hemophilia A Vial von Willebrand Diseases Anesthesia medicine Mild haemophilia A Humans Deamino Arginine Vasopressin business Desmopressin Genetics (clinical) medicine.drug
Zdroj:	Haemophilia : the official journal of the World Federation of Hemophilia. 27(4)
ISSN:	1365-2516
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a1126d596d6e6e18138b8f03a2d0d345 https://pubmed.ncbi.nlm.nih.gov/33684234 Zobrazit plný text záznamu Plný text ve formátu PDF